Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial

BMC Infectious Diseases

Table 4 Regression analysis to determine factors associated with duration of hospitalization

Variables^a		B	Std. Error	t	P Value	95.0% Confidence Interval for B
Variables^a		B	Std. Error	t	P Value	Lower Bound	Upper Bound
	(Constant)	73.438	15.261	4.812	.000	43.129	103.747
	Arbidol group	2.596	.837	3.102	.003	.934	4.258
	Without IHD^b	−3.842	1.482	−2.593	.011	−6.786	−.899
	Without DM^b	.122	1.005	.121	.904	−1.874	2.118
	WBC	.113	.093	1.214	.228	−.072	.298
	Oxygen saturation	−.238	.061	−3.900	.000	−.359	−.117
	Lymphocytosis	−.089	.048	−1.865	.065	−.183	.006
	Na level	−.300	.112	−2.670	.009	−.523	−.077

^aThe White blood cell count (WBC), lymphocytosis, Na level and Oxygen saturation are for the time of admission
^bIschemic heart disease; Diabetes Mellitus

ISSN: 1471-2334